Development and Validation of New Chromatographic Method for the Determination of Enantiomeric and Diastereomeric Purity of Solifenacin Succinate: An Antimuscarinic Agent

<table>Method selectivity as illustrated by a typical chromatogram of solifenacin spiked with its precursor and stereoisomers at 0.15% level. (Chromatographic conditions- Chiralpak-IC, 250 mm <svg height="8.7875004" id="M29" style="vertical-align:-0.3135pt" version="1.1" viewbox="0 0 10.125 8.7875004" width="10.125" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,8.7875)">
<g transform="translate(72,-64.97)">
<text transform="matrix(1,0,0,-1,-71.95,65.34)">
<tspan style="font-size: 12.50px; " x="0" y="0">×</tspan>
</text>
</g>
</g>
</svg> 4.6 mm ID column; mobile phase- n-hexane : ethanol : isopropyl alcohol : diethyl amine (60 : 15 : 25 : 0.1, v/v/v/v); flow rate 1.0 mL/min; column temperature <svg height="11.0375" id="M30" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 20.200001 11.0375" width="20.200001" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.39)">
<tspan style="font-size: 12.50px; " x="0" y="0">3</tspan>
<tspan style="font-size: 12.50px; " x="6.2515001" y="0">0</tspan>
</text>
<text transform="matrix(1,0,0,-1,-59.45,68.56)">
<tspan style="font-size: 8.75px; " x="0" y="0">∘</tspan>
</text>
</g>
</g>
</svg>C; wavelength 220 nm).</table>

Chromatography Research International

fig4

Figure 4

Figure 4: Development and Validation of New Chromatographic Method for the Determination of Enantiomeric and Diastereomeric Purity of Solifenacin Succinate: An Antimuscarinic Agent 

Figure 4 | Development and Validation of New Chromatographic Method for the Determination of Enantiomeric and Diastereomeric Purity of Solifenacin Succinate: An Antimuscarinic Agent 